Skip to content

Clinical trials

Phase 3 Burkitt Lymphoma trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Phase 3 Country / region: New Zealand Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20121
20141
20171
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group3
National Cancer Institute (NCI)3
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma7
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Leukemia, Biphenotypic, Acute2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma2
Anemia, Refractory1
Anemia, Refractory, with Excess of Blasts1
Congenital Abnormalities1
Down Syndrome1
Graft vs Host Disease1
Hodgkin Disease1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.